Medigene AG
XXETR:MDG1Deutsche Borse Xetra- -
EUR
- -
- -
Medigene AG
XETR:MDG1
(Deutsche Borse Xetra)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | EUR | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4.42 | 0.31 | 0.24 | 0.48 | 0.64 | 0.75 | 1.07 | 0.38 | 0.46 | 0.39 | 0.31 | 0.41 | 0.31 | 0.4 | 1.21 | 0.23 | 0.41 | Revenue per Share | |
-3.44 | -2.44 | -1.86 | 0.64 | -1.01 | -1.01 | -0.45 | -0.73 | -0.45 | -0.71 | -0.85 | -0.77 | -1.12 | -0.39 | -0.32 | -0.63 | -0.59 | Basic EPS, GAAP | |
-3.1 | -2.14 | -1.22 | 0.66 | -0.69 | -1.22 | -0.75 | -0.67 | -0.26 | -0.99 | -0.45 | -0.69 | -0.98 | -0.42 | 0.42 | -0.61 | -0.43 | Free Cash Flow per Basic Share | |
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | Dividend per Share | |
-28.95 | -31.03 | -30.75 | -29.68 | -30.69 | -33.24 | -26.36 | -19.56 | -16.44 | -15.87 | -15.18 | -15.4 | -16.51 | -16.9 | -17.22 | -17.85 | -15.4 | Book Value per Share | |
2.83 | 1.12 | 0.7 | 1.84 | 1.49 | 0.7 | 0.83 | 3.07 | 2.5 | 2.53 | 2.69 | 1.78 | 0.83 | 0.57 | 1.05 | 0.43 | 1.78 | Tangible Book Value per Share | |
9 | 9 | 10 | 10 | 10 | 10 | 13 | 18 | 21 | 23 | 25 | 26 | 26 | 26 | 26 | 26 | 26 | Basic Weighted Avg Shares | |
40 | 3 | 2 | 5 | 6 | 8 | 14 | 7 | 10 | 9 | 8 | 11 | 8 | 10 | 31 | 6 | 11 | Sales/Revenue/Turnover | |
-63.8 | -908.19 | -1,203.93 | -336.21 | -163.49 | -109.08 | -20.9 | -153.33 | -135.56 | -178.81 | -229.88 | -189.63 | -291.59 | -95.43 | -27.93 | -267.63 | -189.63 | Operating Margin (%) | |
7 | 1 | 10 | 5 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 6 | 3 | 22 | 1 | - - | Depreciation Expense | |
-31 | -22 | -18 | 6 | -10 | -10 | -6 | -13 | -9 | -16 | -21 | -20 | -29 | -10 | -8 | -16 | -15 | Net Income, GAAP | |
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | Effective Tax Rate (%) | |
-77.74 | -788.58 | -779.62 | 134.9 | -156.89 | -135.43 | -41.77 | -190.94 | -97.36 | -180.02 | -273.74 | -187.75 | -360.85 | -95.41 | -26.66 | -268.1 | -143.75 | Profit Margin (%) | |
21 | 7 | 1 | 13 | 20 | 11 | 17 | 50 | 54 | 55 | 49 | 48 | 23 | 16 | 30 | 11 | 48 | Working Capital | |
- - | - - | - - | - - | - - | 10 | - - | 1 | - - | 1 | 1 | 5 | 4 | 3 | 3 | 2 | 5 | LT Debt | |
65 | 52 | 41 | 48 | 44 | 36 | 49 | 90 | 88 | 93 | 103 | 82 | 53 | 45 | 37 | 21 | 82 | Total Equity | |
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | Return on Invested Capital (%) | |
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | Return on Capital (%) | |
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | Return on Common Equity (%) |
Growth Rates
EUR
•
in mil. unless spec.(avg. rate of change) | 10 years | 5 years | 1 year |
|---|---|---|---|
Total Equity | 0.11% | -26.39% | -43.1% |
Free Cash Flow | -19.38% | -80.02% | -243.89% |
Net Income, GAAP | 20.69% | 10.18% | 94.2% |
Sales/Revenue/Turnover | 21.36% | 32.22% | -80.69% |
Total Cash Common Dividend | - - | - - | - - |
Quarterly Revenue
EUR
•
in mil. unless spec.Year | Q1 | Q2 | Q3 | Q4 | FY |
|---|---|---|---|---|---|
2022 | - - | 2 | - - | - - | 31 |
2023 | - - | 2 | - - | - - | 6 |
2024 | - - | 1 | - - | - - | - - |
Quarterly Earnings Per Share
EUR
•
in mil. unless spec.Year | Q1 | Q2 | Q3 | Q4 | FY |
|---|---|---|---|---|---|
2022 | - - | -0.09 | - - | - - | -0.32 |
2023 | - - | -0.17 | - - | - - | -0.63 |
2024 | - - | -0.15 | - - | - - | - - |
Quarterly Dividends Per Share
EUR
•
in mil. unless spec.Year | Q1 | Q2 | Q3 | Q4 | FY |
|---|---|---|---|---|---|
2022 | - - | - - | - - | - - | - - |
2023 | - - | - - | - - | - - | - - |
2024 | - - | - - | - - | - - | - - |
- Similar Companies
- Business